Related Experiment Video
Updated: Feb 24, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Risk of injury associated with the sedative potential of second-generation antihistamines: A nationwide retrospective
Jumpei Taniguchi1, Shotaro Aso2, So Sato1
1Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
Aim:
Individual second-generation antihistamines may possess differential sedative potential due to the variability in central histamine receptor H1 occupancy. This study aimed to evaluate whether the sedative potential of second-generation antihistamines is associated with the risk of injury during Japan's pollen season.
Methods:
We conducted a retrospective cohort study using data acquired from a nationwide health insurance claims database in Japan. We enrolled patients with allergic rhinitis who were newly prescribed oral second-generation antihistamines during the pollen season (January-May) between 2006 and 2022. Antihistamines were categorized into two groups based on the estimated central histamine receptor H1 occupancy: ≥ 10% (higher-sedation group: cetirizine, levocetirizine, loratadine, olopatadine and bepotastine) and < 10% (lower-sedation group: fexofenadine, bilastine and desloratadine). The proportions of newly diagnosed injuries during the same pollen season were compared between the higher-sedation and lower-sedation groups using propensity score overlap weighting. Subgroup analysis that stratified patients by age (< 65 and ≥ 65 years) was also conducted.
Results:
Among 1 313 550 eligible patients, 50.2% and 49.8% received higher-sedation and lower-sedation antihistamines, respectively. After overlap weighting, no significant difference in injury risk was observed between the groups (2.6% vs. 2.6%; risk difference, -0.0%; 95% confidence interval, -0.1 to 0.0; P = 0.388). Subgroup analysis showed consistent results across the age groups.
Conclusion:
In this large nationwide cohort of patients with allergic rhinitis, second-generation antihistamines with higher vs. lower sedative potential showed no difference in injury risk during Japan's pollen season.
More Related Videos
Related Concept Videos
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Barbiturates
CNS Depressants: Barbiturates and Benzodiazepines

